Effect of dietary n-3 fatty acids supplementation on fatty acid metabolism in atorvastatin-administered SHR.Cg-Leprcp/NDmcr rats, a metabolic syndrome model
Long-term administration of atorvastatin inhibits n-3PUFAs synthesis in the liver. Long-term administration of atorvastatin inhibits Δ5-desaturase, Δ6-desaturases and elongase-5 mRNA expression in liver. Dietary n-3PUFAs supplementation restore the decreased n-PUFAs level in liver.